Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ascrinvacumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 898 Fluorouracil 729 Capecitabine 670 Gemcitabine 576 Leucovorin 510 Irinotecan 482 Bevacizumab 451 Radiotherapy 419 Cisplatin 384 Drug Therapy 266 Cetuximab 250 Surgical Procedures, Operative 207 Paclitaxel 207 S 1 (combination) 199 Docetaxel 183 pembrolizumab 180 130-nm albumin-bound paclitaxel 173 Nivolumab 170 Sorafenib 163 Radiosurgery 163 apatinib 161 sintilimab 160 Folfox protocol 160 lenvatinib 156 Albumin-Bound Paclitaxel 152 camrelizumab 143 Neoadjuvant Therapy 143 Blood Specimen Collection 142 tislelizumab 138 durvalumab 137

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02116894 2019-03-14

REGAL-1

Duke University

Phase 1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡